Boston Scientific Corp (BSX)vsHeart Test Laboratories Inc. Common Stock (HSCS)
BSX
Boston Scientific Corp
$42.98
-0.28%
HEALTHCARE · Cap: $62.29B
HSCS
Heart Test Laboratories Inc. Common Stock
$3.39
-3.42%
HEALTHCARE · Cap: $13.56M
Smart Verdict
WallStSmart Research — data-driven comparison
Boston Scientific Corp generates 486130949% more annual revenue ($21.00B vs $4,319). BSX leads profitability with a 17.5% profit margin vs 0.0%. BSX earns a higher WallStSmart Score of 72/100 (B).
BSX
Strong Buy72
out of 100
Grade: B
HSCS
Avoid13
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-10.0%
Fair Value
$39.07
Current Price
$42.98
$3.91 premium
Intrinsic value data unavailable for HSCS.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Growing faster than its price suggests
Attractively priced relative to earnings
Reasonable price relative to book value
Strong operational efficiency at 22.9%
Generating 1.3B in free cash flow
No standout strengths identified
Areas to Watch
Distress zone — elevated risk
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : BSX
The strongest argument for BSX centers on Market Cap, PEG Ratio, P/E Ratio. Profitability is solid with margins at 17.5% and operating margin at 22.9%. PEG of 0.60 suggests the stock is reasonably priced for its growth.
Bull Case : HSCS
HSCS has a balanced fundamental profile.
Bear Case : BSX
The primary concerns for BSX are Altman Z-Score.
Bear Case : HSCS
The primary concerns for HSCS are EPS Growth, Market Cap, Profit Margin. Debt-to-equity of 17.41 is elevated, increasing financial risk.
Key Dynamics to Monitor
BSX profiles as a mature stock while HSCS is a value play — different risk/reward profiles.
HSCS carries more volatility with a beta of 1.80 — expect wider price swings.
BSX is growing revenue faster at 7.5% — sustainability is the question.
BSX generates stronger free cash flow (1.3B), providing more financial flexibility.
Bottom Line
BSX scores higher overall (72/100 vs 13/100), backed by strong 17.5% margins. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Boston Scientific Corp
HEALTHCARE · MEDICAL DEVICES · USA
Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
Heart Test Laboratories Inc. Common Stock
HEALTHCARE · MEDICAL DEVICES · USA
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company is headquartered in Southlake, Texas.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?